Annachiara Rosa

POSTDOCTORAL TRAINING FELLOW

Three-dimensional model of the retroviral intasome and chemical structures of some of the clinical HIV-1 integrase inhibitors studied in the lab

Cherepanov lab

Chromatin structure and mobile DNA Laboratory

Email Address:
Email

Qualifications and history

2016

PhD in Biomolecular Sciences

2012

MSc in Molecular and Cell Biology

2009

BSc in Biology

Displaying 1 - 13 of 13

Last updated : 30 March 2023 03:45

Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies

Authors (23)

Maryam Khan
Carolina Rosadas
Ksenia Katsanovskaja
Isaac D Weber
Justin Shute
Samreen Ijaz
[...]
Graham S Cooke
Peter Cherepanov
Eleanor Parker
Myra O McClure
Richard S Tedder

Scientific Reports

Published 3 February 2022

Crick labs/ facilities

Full details

Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility

Authors (39)

Carolina Rosadas
Maryam Khan
Eleanor Parker
Federica Marchesin
Ksenia Katsanovskaja
Macià Sureda-Vives
[...]
Malcolm G Semple
Peter Cherepanov
Myra O McClure
Richard S Tedder
ISARIC4C Investigators

Journal of Virological Methods

Published 1 April 2022

Crick labs/ facilities

Full details

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

Authors (21)

Aljawharah Alrubayyi
Ester Gea-Mallorquí
Emma Touizer
Dan Hameiri-Bowen
Jakub Kopycinski
Bethany Charlton
[...]
Tao Dong
Lucy Dorrell
Sarah Rowland-Jones
Laura E McCoy
Dimitra Peppa

Nature Communications

Published 5 October 2021

Crick labs/ facilities

Full details

Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases

Authors (31)

Claire T Deakin
Georgina H Cornish
Kevin Ng
Nikhil Faulkner
William Bolland
Joshua Hope
[...]
Michael Levin
Peter Cherepanov
Coziana Ciurtin
Lucy R Wedderburn
George Kassiotis

Med

Published 10 September 2021

Crick labs/ facilities

Full details

Neutralizing antibody responses after SARS-CoV-2 infection in end-stage kidney disease and protection against reinfection

Authors (15)

L Muir
A Jaffer
C Rees-Spear
V Gopalan
FY Chang
R Fernando
[...]
GK Rajakaruna
Peter Cherepanov
A Salama
LE McCoy
R Motallebzadeh

Kidney International Reports

Published 1 July 2021

Crick labs/ facilities

Full details

SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity

Authors (40)

Annachiara Rosa
Val Pye
Carl Graham
Luke Muir
Jeffrey Seow
Kevin Ng
[...]
Richard S Tedder
George Kassiotis
Laura E Mccoy
Katie J Doores
Peter Cherepanov

Science advances

Published 28 May 2021

Crick labs/ facilities

Full details

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

Authors (29)

Carl Graham
Jeffrey Seow
Isabella Huettner
Hataf Khan
Neophytos Kouphou
Sam Acors
[...]
Laura E McCoy
Adrian Hayday
Stuart JD Neil
Michael H Malim
Katie J Doores

Immunity

Published 8 June 2021

Crick labs

Full details

The effect of spike mutations on SARS-CoV-2 neutralization

Authors (22)

Chloe Rees-Spear
Luke Muir
Sarah A Griffith
Judith Heaney
Yoann Aldon
Jonne L Snitselaar
[...]
Eleni Nastouli
SAFER Investigators
Katie J Doores
Marit J van Gils
Laura E McCoy

Cell Reports

Published 23 March 2021

Crick labs/ facilities

Full details

Severe acute respiratory syndrome coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting

Authors (21)

Ellen C Hughes
Julien AR Amat
Joanne Haney
Yasmin A Parr
Nicola Logan
Norah Palmateer
[...]
Elizabeth Dickson
Rory N Gunson
Mafalda Viana
Brian J Willett
Pablo R Murcia

Journal of Infectious Diseases

Published 15 March 2021

Crick labs

Peter Cherepanov

Full details

SARS-CoV-2 antibody responses in patients with acute leukaemia

Authors (12)

J O'Nions
L Muir
J Zheng
C Rees-Spear
Annachiara Rosa
Chloe Roustan
[...]
Peter Cherepanov
R Gupta
A Khwaja
C Jolly
LE McCoy

Leukemia

Published 1 January 2021

Crick labs/ facilities

Full details

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Authors (47)

Kevin Ng
Nikhil Faulkner
Georgina H Cornish
Annachiara Rosa
Ruth Harvey
Saira Hussain
[...]
Steve Gamblin
Laura E Mccoy
Peter Cherepanov
Eleni Nastouli
George Kassiotis

Science

Published 11 December 2020

Crick labs/ facilities

Full details

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

Authors (341)

Catherine F Houlihan
Nina Vora
Thomas Byrne
Dan Lewer
Gavin Kelly
Judith Heaney
[...]
Andrew Hayward
Richard Gilson
Gavin Kelly
Fiona Roberts
Emine Hatipoglu

A bipartite structural organization defines the SERINC family of HIV-1 restriction factors

Authors (17)

Val Pye
Annachiara Rosa
Cinzia Bertelli
Weston B Struwe
Sarah L Maslen
Robin Corey
[...]
Phillip J Stansfeld
Mark Skehel
Carol V Robinson
Massimo Pizzato
Peter Cherepanov

Nature Structural and Molecular Biology

Published 6 January 2020

Crick labs/ facilities

Full details

Coronavirus (COVID-19) response

Vacancies

Outwitting Cancer

Coronavirus (COVID-19) research

About us

Annachiara Rosa

POSTDOCTORAL TRAINING FELLOW

Cherepanov lab

Qualifications and history

Year published

Research topics

Publication type

Journal

Crick Pre-Crick

Simple, sensitive, specific self-sampling assay secures SARS-CoV-2 antibody signals in sero-prevalence and post-vaccine studies

Detection and quantification of antibody to SARS CoV 2 receptor binding domain provides enhanced sensitivity, specificity and utility

Characterization of humoral and SARS-CoV-2 specific T cell responses in people living with HIV

Favourable antibody responses to human coronaviruses in children and adolescents with autoimmune rheumatic diseases

Neutralizing antibody responses after SARS-CoV-2 infection in end-stage kidney disease and protection against reinfection

SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant

The effect of spike mutations on SARS-CoV-2 neutralization

Severe acute respiratory syndrome coronavirus 2 serosurveillance in a patient population reveals differences in virus exposure and antibody-mediated immunity according to host demography and healthcare setting

SARS-CoV-2 antibody responses in patients with acute leukaemia

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers

A bipartite structural organization defines the SERINC family of HIV-1 restriction factors

The Francis Crick Institute is a unique partnership between